Treatment

Treatment

Resistance: When RET Non-Small Cell Lung Cancer Treatments Stop Working

Cancer drug resistance means that a tumor no longer responds to anticancer drugs that were…

rdsupportJune 24, 2024

Research Treatment

American Society of Clinical Oncology Annual Meeting 2024

The 2024 ASCO Annual Meeting, held May 31-June 4 in Chicago, IL, brought together more…

rdsupportJune 18, 2024

Treatment

Current Treatment Options for RET Lung Cancer

Lung cancer staging matters. Why? So your doctor can properly assess the spread of disease…

rdsupportJune 5, 2024

Research Treatment

IASLC Targeted Therapies Recap

#TogetherSeparately: live virtual meetup to summarize data presented on February’s IASLC Targeted Therapies Meeting. March 13 at 3PM…

rdsupportMarch 11, 2024

Treatment

RET inhibitor Granted Fast Track by FDA

Ellipses’ next generation selective RET inhibitor EP0031/A400 granted Fast Track designation by FDA Ellipses Pharma…

rdsupportMarch 11, 2024

Clinical Trials Treatment

The Harmonic™ Clinical Trial for Never Smokers

New clinical trial for never smokers: The Harmonic™ clinical trial The Harmonic™ clinical trial is…

rdsupportMarch 9, 2024

Nino's News Research Treatment

Looking Ahead: The Future of Diagnostic Testing for Patients

Over the last fifteen years, the introduction of precision medicine has generated renewed hope for…

rdsupportJanuary 7, 2024

News Research Treatment

2023 RET Cancer Research Update

2023 Happy Lungs Project RET research update On Friday December 8th, the Happy Lungs Project…

rdsupportDecember 18, 2023

Research Treatment

Exciting Preclinical Results About Vepafestinib

New published study with exciting preclinical results about the second generation RET inhibitor vepafestinib (TAS0953/HM06). Vepafestinib showed selectivity…

rdsupportOctober 10, 2023

Clinical Trials Treatment

New clinical trial testing amivantamab

New clinical trial testing amivantamab for patients who progressed on RET therapies: A Phase 1…

rdsupportOctober 8, 2023

The mission of The Happy Lungs Project is to save the lives of RET-positive lung cancer patients by advancing research and treatment options.

Email: info@happylungsproject.org

Address: 3209 Sunny Ln. Austin, TX 78731

Scientific research can be confusing and overwhelming

Receive emails about RET-positive research and what it means for current treatment options and future therapies.

Popular Posts